We have found 410 documents matching your search criteria

  1. Wound Healing & Bioactive Dressings | X-Pure Gelatin | Rousselot Biomedical

    Wound healing Wound healing presents one of the greatest challenges for healthcare today, with post-surgical complications and chronic wound costs greater than those for asthma, dementia, or obesity. [1] Helping the body to heal itself For topical and in-body wounds, X-Pure® low endoxtoxin gelatins

  2. Sustainability week at Rousselot Brazil

    The Sustainability Week was conceived in 2019, but delayed until October 2021 due to the Covid-19 pandemic. Its goal is to highlight different sustainability projects colleagues have been involved in, while also inspiring school students to take environmental action. Connecting through environmental

  3. Implantable Membranes | Biocompatible Gelatin | Rousselot Biomedical

    Implantable membranes Implantable fibrous membranes can act as scaffolds to support tissue following trauma or surgical procedures, but should be made from ultra-pure, highly biocompatible, and bio-absorbable materials . Surgical recovery can be complicated by endotoxins Residual endotoxins can be a

  4. Customer Product Pipeline | Pharmaceutical Excipients | Rousselot Biomedical

    Customer Product Pipeline Rousselot Biomedical’s gelatins are currently being used in a range of different in vitro and in vivo applications in quantities appropriate for research as well as commercial product development. Customers across the world are benefiting from our X-Pure® range of versatile

  5. A new green roof in Ghent

    The city of Ghent is strongly committed to the environment and is carrying out numerous actions in this field such as the implementation of a low-emission zone without high-polluting vehicles. In the same spirit, Rousselot Ghent’s plant is committed to limiting the impact of its industrial activitie

  6. Rousselot adds porcine collagen production line at flagship Ghent facility

    Irving, Texas, January 26, 2022 – Rousselot ® , Darling Ingredients’ health brand, and the global leader of collagen-based solutions, [i] announces an increase in its production capabilities for porcine collagen, responding to rising demand for premium collagen ingredients. The newly opened producti

  7. Rousselot Announces Partnership with Terasaki Institute for Biomedical Innovation

    Through this strategic partnership, Rousselot and TIBI will collaborate on the development of gelatin-based therapies and their translation to the clinic. Rousselot will supply TIBI with X-Pure® modified gelatins such as X-Pure GelMA , while exchanging insights on the behavior of gelatin in the inst

  8. Joining forces to reduce waste in Charente, France

    Setting waste reduction objectives Between October and November 2020, Rousselot Angoulême analyzed its waste production and mapped the route of its waste products to work out its carbon footprint. After the results, the team outlined clear steps for improvement. These include, the following three: F

  9. Parenteral Formulation | Pharma Grade Gelatin for Vaccines | Rousselot Biomedical

    Parenteral Formulation, vaccines Today’s parenteral formulation industry is growing rapidly. In the vaccine space, government organizations worldwide are launching increasing numbers of programs to combat the rising prevalence of infectious diseases and the demand for excipients as safe carriers in

  10. Rousselot Innovation Days - Practical information

    Did you watch the movie of our Innovation Days 2022? Get a glimpse of these two days… Practical Information Dates 19th April, 2023 – from 2:00 pm to 6:00 pm, followed by a dinner up to 10:00 pm 20th April, 2023 – from 9:00 am to 2:00 pm, including a a light lunch Please make sure to be present at le